Kiran Mazumdar-Shaw

Insider Reports History

Location
Boston, MA
Signature
/s/ Lara Meisner, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kiran Mazumdar-Shaw:

Company Role Class Num Shares Value Price $ Report Date Ownership
Bicara Therapeutics Inc. Director, 10%+ Owner Common Stock 4,443,122 $58,842,042 $13.24 16 Sep 2024 By Biocon Limited
Bicara Therapeutics Inc. Director, 10%+ Owner Common Stock 1,080,775 $14,313,136 $13.24 16 Sep 2024 By Biocon Pharma Inc.
Bicara Therapeutics Inc. Director, 10%+ Owner Common Stock 432,736 $5,730,896 $13.24 16 Sep 2024 By Carica Investments
Bicara Therapeutics Inc. Director, 10%+ Owner Common Stock 324,552 $4,298,172 $13.24 16 Sep 2024 By Glentech International
Bicara Therapeutics Inc. Director, 10%+ Owner Stock Option (Right to Buy) 23,746 09 Jun 2025 Direct
Bicara Therapeutics Inc. Director, 10%+ Owner Series Seed Redeemable Convertible Preferred Stock 0 16 Sep 2024 By Biocon Limited
Bicara Therapeutics Inc. Director, 10%+ Owner Series Seed Redeemable Convertible Preferred Stock 0 16 Sep 2024 By Biocon Pharma Inc.
Bicara Therapeutics Inc. Director, 10%+ Owner Series Seed Redeemable Convertible Preferred Stock 0 16 Sep 2024 By Carica Investments
Bicara Therapeutics Inc. Director, 10%+ Owner Series Seed Redeemable Convertible Preferred Stock 0 16 Sep 2024 By Glentech International

Insider Reports Filed by Kiran Mazumdar-Shaw

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BCAX Bicara Therapeutics Inc. 09 Jun 2025 1 $0 4 Director, 10%+ Owner 10 Jun 2025, 16:31
BCAX Bicara Therapeutics Inc. 12 Sep 2024 9 $0 4 Director, 10%+ Owner 16 Sep 2024, 16:35
BCAX Bicara Therapeutics Inc. 12 Sep 2024 0 $0 3 Director, 10%+ Owner 12 Sep 2024, 21:11